Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558949 | PMC |
| http://dx.doi.org/10.1055/s-0041-1736563 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings.
PLoS One
December 2024
Clínica Colsanitas and Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Background: Despite declining COVID-19 incidence, healthcare workers (HCWs) still face an elevated risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. We developed a diagnostic multivariate model to predict positive reverse transcription polymerase chain reaction (RT-PCR) results in HCWs with suspected SARS-CoV-2 infection.
Methods: We conducted a cross-sectional study on episodes involving suspected SARS-CoV-2 symptoms or close contact among HCWs in Bogotá, Colombia.
Genome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19.
medRxiv
December 2024
Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, IA 52242, USA.
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N=187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N=947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients.
View Article and Find Full Text PDFEfficacy of Platelet-Rich Plasma in the Treatment of Persistent Olfactory Impairment After COVID-19: A Systematic Review and Meta-Analysis.
J Rhinol
March 2024
Department of Otolaryngology-Head and Neck Surgery, Bucheon Saint Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Background And Objectives: This study aimed to evaluate the impact of topical platelet-rich plasma (PRP) injection on persistent refractory olfactory dysfunction after COVID-19 infection.
Methods: A systematic review was conducted, focusing on studies that compared the efficacy of topical PRP treatment with a control group (receiving either placebo or no treatment) in ameliorating olfactory dysfunction. Pre- and post-treatment comparisons were evaluated, along with a subgroup analysis of olfactory function evaluation.
Rates, Risk Factors and Outcomes of Complications After COVID-19 in Children.
Pediatr Infect Dis J
December 2024
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok.
Background: Coronavirus disease 2019 (COVID-19) can lead to various complications, including multisystem inflammatory syndrome in children (MIS-C) and post-COVID-19 conditions (long COVID). This study aimed to determine the rates, risk factors and outcomes of MIS-C and long COVID in children previously diagnosed with COVID-19.
Methods: This study was a combined retrospective and prospective cohort study.
Olfactory dysfunction in COVID-19; Self-report or olfactory dysfunction test?
Caspian J Intern Med
October 2024
Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Article Synopsis
- - Researchers examined the differences between self-reported smell disorders and those identified through specific tests in COVID-19 patients, reviewing 554 studies from late 2019 to 2020 using systematic methods to categorize findings.
- - Out of the analyzed studies, 80% relied on patient self-reports regarding olfactory dysfunction, while only 20% utilized specific tests; the results showed a broad range of prevalence in self-reported cases (20%-97%) compared to a much higher incidence of anosmia (65%-98%) in those tested.
- - The study concluded that while self-reporting is convenient and cost-effective, standardized tests yield more reliable results, highlighting the need for precise screening methods in assessing COVID-19 related
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!